Pharmaceuticals & Healthcare Products
186 posts · page 2 of 8

The rising role of specialty drugs and biologics in India’s export mix
India's specialty drugs are transforming global healthcare exports.

The state of clinical trials in India and recent reforms to attract global studies
India's reforms boost clinical trials, attracting global interest.

The future of Indian obesity drug pipelines and the global race to develop novel molecules
India's obesity drug pipeline is vital for global health innovation.

Pharma exporters seeking rollback of export bans on India-only drugs and its policy implications
Pharma exporters push to lift bans on India-only drug exports.

Quality standards and the quest for compliance with USFDA and EU GMP norms
Navigating USFDA and EU GMP norms ensures product safety.

Effect of geopolitical tensions on pharma raw material sourcing strategies
Geopolitical tensions reshape pharma sourcing strategies dramatically.

Evolution of pharma R&D funding and collaboration trends in India
India's pharma R&D funding is evolving with new collaborations.

The role of pharma in achieving India’s public health and affordability goals
Pharma plays a crucial role in enhancing India’s public health.

Digitization in pharma regulation with e-governance and approval portals
E-governance transforms pharma regulation and approval processes.

Opportunities in neglected and rare diseases for Indian pharma innovation
Unlocking new potential in rare disease innovation in India.

Trends in domestic consumption versus exports in Indian pharmaceuticals
India's pharmaceutical sector is evolving, balancing local needs and global demands.

Policy reforms shaping India as a manufacturing hub for pharma and devices
India's policy reforms are transforming its pharma manufacturing landscape.

How stock market performance is influencing pharma investor confidence
Pharma stocks are swinging as market trends shift investor trust.

Impact of price erosion after patent expiry with case studies from recent launches
Price erosion post-patent expiry reshapes market dynamics.

Talent and skill development challenges in pharma manufacturing
Pharma manufacturing faces urgent talent and skill gaps.

The outlook for biotech and biosimilars in the Indian market
India's biotech and biosimilars market shows promising growth.

How mergers and acquisitions are reshaping the competitive landscape
Mergers and acquisitions are redefining industry dynamics.

Regulatory oversight of pharma advertising and promotion in India
India tightens regulations on pharma advertising practices.

Venture capital and startup trends in Indian pharma and biotech
Exploring the rise of venture capital in India's pharma sector.

The rising importance of wellness and preventive care in pharma portfolios
Wellness and preventive care are reshaping pharma strategies.

Export incentives and trade policy changes affecting pharma companies
Pharma firms navigate new export incentives and trade shifts.

Price regulation and updates to Drug Price Control Orders
Exploring the impact of Drug Price Control Orders on healthcare.

Investment in local API parks and their expected outcomes
Local API parks promise economic growth and community benefits.

Pharma innovation clusters and their potential for scaling research
Pharma clusters boost collaboration, driving research breakthroughs.
